National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

GIOTRIF as monotherapy is indicated for the treatment of Epidermal Growth Factor Receptor (EGFR) TKI-naïve adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating EGFR mutation(s).

 Rapid Review

Commenced Completed Outcome
01/10/2013 13/10/2013 Full HTA not recommended